Asking Price: Not Disclosed Gross Revenue: $1,687,000Cash Flow: Not DisclosedEBITDA: $211,000Inventory: Not Disclosed FF&E: Not Disclosed included in asking priceReal Estate: Not Disclosed Share this business:
Explanation of Financial Terms
The total asking price of the business for sale.
All income the business received before any cost-of-sales or expenses have been deducted.
Arrived at by "starting with your net (before tax) profit. Then, add back in any payments made to the owner, interest and any depreciation of assets." For example, if the net profit before taxes was $100,000 and the owner was paid $70,000 then the cash flow is $170,000.
Earnings Before Interest, Taxes, Depreciation and Amortization.
The value of the merchandise, raw materials, and finished and unfinished products which have not yet been sold. If there is no inventory price listed then the seller did not provide it.
Furniture, fixtures and equipment that will remain with the business, such as desks, office cubicles, decor elements of a restaurant or showroom, computers and office machines, pots and pans, dishes, display cases, manufacturing equipment, etc., depending on the type of business.
The value of property owned by the business. May be included in the asking price or offered separately. If no real estate value is listed, it was not provided by the seller.
The Company is an independent clinical research site. It provides exceptional expertise in an array of therapeutic areas of medicine as they relate to the research of drugs, vaccines, and medical devices.
· Trait-searchable management database of over 22,000 potential subjects
· Experienced Physicians in all aspects of clinical research
· Licensed nurses with a minimum of eight years clinical research experience
· Expanded Company budgets for current and upcoming studies that have been negotiated to an average of 22% above initial offers
· Broad range of clinical indications with studies in pulmonary, allergy, internal medicine, vaccines, and devices
· The reason for the decline in 2017 was the discontinuity of the allergic rhinitis research. In 2017, the company had multiple major projects get put on "hold", a usual industry occurrence, according to management
About the Business
Headquartered · San Antonio, Texas
Real estate · The Company leases one suite in a Class A Medical Office Building in San Antonio, Texas from an unrelated third party. The building is one block from The University of Texas Health Science Center.
Current markets · The Company provides services to pharmaceutical, vaccine, and device companies from the United States, Canada, Europe, India, and Japan.
Shareholder/owner objectives · Two active owners seek a full sale of the business as they are anticipating retirement. All other partners are inactive; however, the majority shareholder and the other owner believe that selling is an exit strategy for them that will allow them to continue working for additional years. The two physicians who are seeking retirement are willing to remain onboard as investigators until retirement.
Growth & Expansion:
Opportunities · Hire dedicated business development specialist · Expand operations to add additional site locations and centralize business development · Explore additional studies regarding new pharmaceuticals and vaccines that are being developed · Increase subject base
The information on this listing has been provided by either
the seller or a business broker representing the seller. BizQuest has no interest
or stake in the sale of this business and has not verified any of the information
and assumes no responsibility for its accuracy, veracity, or completeness. See our
full Terms & Conditions.